Menthol

Menthol

SCHEMBL1664660

CC(=O)O.CC1CCC(C(C)C)C(O)C1

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of Menthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 5/20 0.81
TRPA1 known ✓ O75762 2/20 0.81
EPHX1 P07099 3/20 0.53
KCNA5 P22460 1/20 0.41
TRPV1 Q8NER1 4/20 0.40
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Menthol SCHEMBL1664554 0.94 TRPM8 (0.84) TRPM8TRPA1EPHX1KCNA5TRPV1
Menthol SCHEMBL20586546 0.92 TRPM8 (0.81) TRPM8TRPA1EPHX1KCNA5TRPV1
Menthol SCHEMBL13730660 0.92 TRPM8 (0.68) TRPM8TRPA1EPHX1KCNA5TRPV1
Menthol SCHEMBL2125538 0.91 TRPM8 (0.78) TRPM8TRPA1EPHX1KCNA5TRPV1
Menthol SCHEMBL2124686 0.91 TRPM8 (0.78) TRPM8TRPA1EPHX1KCNA5TRPV1
Menthol SCHEMBL28455572 0.90 TRPM8 (0.84) TRPM8TRPA1EPHX1KCNA5TRPV1
(+)-Menthol SCHEMBL10072505 0.90 TRPM8 (1.00) TRPM8TRPA1EPHX1KCNA5TRPV1
(+)-Menthol SCHEMBL12646785 0.90 TRPM8 (1.00) TRPM8TRPA1EPHX1KCNA5TRPV1
(+)-Menthol SCHEMBL15449169 0.90 TRPM8 (1.00) TRPM8TRPA1EPHX1KCNA5TRPV1
Menthol SCHEMBL20771511 0.90 TRPM8 (1.00) TRPM8TRPA1EPHX1KCNA5TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260114787-A1 Olfactory Diagnostic Compositions and Kits, and Methods of Making and Using the Same UNIV KANSAS (US) 2026-04-30 US claimed
CN-117625305-A Preparation process of natural essential oil for joint maintenance 香赞珈蓝(上海)健康科技有限公司 2024-03-01 CN claimed
CN-114504511-B Powdery cosmetic composition 上海百雀羚生物科技有限公司 2024-02-23 CN claimed
CN-114504511-A Powdery cosmetic composition 上海百雀羚生物科技有限公司 2022-05-17 CN claimed
CN-114469771-A Multifunctional anti-dandruff refreshing shampoo and preparation method thereof 上海章华保健化妆品有限公司 2022-05-13 CN claimed
US-20220047476-A1 A METHOD FOR FIGHTING FEMALE BODY ODORS SYMRISE AG (DE) 2022-02-17 US claimed
CN-113599569-A Bioabsorbable collagen-based medical glue and preparation method thereof 南通伊诺精密塑胶导管有限公司 2021-11-05 CN claimed
CN-111802409-B Broad-spectrum antiviral antibacterial disinfectant and preparation method and application thereof 武汉理工大学 2021-10-29 CN claimed
CN-112955230-A A method for resisting female body odor 西姆莱斯股份公司 2021-06-11 CN claimed
CN-109030459-B Method for rapidly detecting menthol content based on Raman spectrum 天津市天大赛达协同创新科技研究院有限公司 2021-03-16 CN claimed
CN-111802409-A Broad-spectrum antiviral antibacterial disinfectant and preparation method and application thereof 武汉理工大学 2020-10-23 CN claimed
CN-111166702-A Temperature-sensitive skin firming cream 广州珂菲施诺生物科技有限公司 2020-05-19 CN claimed
CN-110628290-A Formula and manufacturing method of cool butyronitrile gloves 山东英科医疗制品有限公司 2019-12-31 CN claimed
CN-109030459-A A method of menthol content is quickly detected based on Raman spectrum 天津市天大赛达协同创新科技研究院有限公司 2018-12-18 CN claimed
US-20170014463-A1 Composition Comprising Plants Extracts that Synergistically Treat or Inhibit Pathological Conditions and Method of Making NOLAN BRUCE (US) 2017-01-19 US claimed
US-20080032913-A1 Masking of mineral oil odor and fragrancing of mineral oils SYMRISE GMBH & CO. KG (DE) 2008-02-07 US claimed
US-20050042308-A1 Pharmaceutical composition having cholagogic and litholytic effect and its preparation method JIANGSU KANION PHARMACEUTICALS CO., LTD. (CN) 2005-02-24 US claimed
US-20260114787-A1 Olfactory Diagnostic Compositions and Kits, and Methods of Making and Using the Same UNIV KANSAS (US) 2026-04-30 US disclosed
US-5397573-A Side effect reduction THE PROCTER & GAMBLE COMPANY (US) 1995-03-14 US disclosed
WO-1990008553-A1 TRANSDERMAL DRUG DELIVERY COMPOSITION ABBOTT LABORATORIES (US) 1990-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260114787-A1 Olfactory Diagnostic Compositions and Kits, and Methods of Making and Using the Same OR51E2, OR10J3, TAS2R5 TRPM8 268/4885TRPA1 33/4885EPHX1 73/4885
US-20220047476-A1 A METHOD FOR FIGHTING FEMALE BODY ODORS SHBG, C5, CUTA TRPM8 2189/4885TRPA1 1305/4885EPHX1 2118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.